Kiniksa Pharmaceuticals International plc – Material Contracts Watch

from 8-K 8 pages Background (A) the Authorised Share Capital of the Company Comprises, Inter Alia, a Ordinary Shares, A1 Ordinary Shares, B Ordinary Shares and B1 Ordinary Shares (Each as Defined in the Articles, and Together, the “Shares”). ​ (B) the Shareholders Are, Together, the Registered Holders of the Relevant Shares. Baker Brothers and 667, L.P. Are Affiliates. ​ (C) Pursuant to Article 5.4 of the Articles, Holders of Certain Classes of Equity Shares Have the Right to Convert Those Shares Into Either a Ordinary Shares or B Ordinary Shares (The “Conversion Rights”). ​ (D) the Adviser on Behalf of the Shareholders Has Agreed to Waive, Irrevocably and Unconditionally, Any and All Conversion Rights the Shareholders May Have in Respect of the Relevant Shares on the Terms Set Out in This Deed. It Is Agreed as Follows: 1. Interpretation ​ 1.1. in This Deed

from 10-Q 4 pages Kiniksa Pharmaceuticals International, PLC. ​ Non-Employee Director Compensation Program

from 10-K 4 pages Kiniksa Pharmaceuticals International, PLC. ​ Non-Employee Director Compensation Program

from 10-K 7 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(a)(6) ​ Consulting Agreement

from 10-Q 12 pages Employment Agreement ​

from 10-Q 29 pages Kiniksa Pharmaceuticals International, PLC 2018 Incentive Award Plan

from 10-Q 7 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(a)(6) ​ Consulting Agreement

from 10-Q 8 pages Kiniksa Pharmaceuticals International, PLC 2018 Incentive Award Plan Performance-Based Restricted Share Unit Grant Notice

from 8-K 6 pages Kiniksa Pharmaceuticals International, PLC 2018 Incentive Award Plan Share Option Grant Notice – FDA Approval Milestone

from 8-K 6 pages Kiniksa Pharmaceuticals International, PLC 2018 Incentive Award Plan Share Option Grant Notice – Bla Filing Milestone

from 8-K 5 pages Kiniksa Pharmaceuticals International, PLC 2018 Incentive Award Plan Performance Restricted Share Unit Grant Notice – FDA Approval Milestone

from 8-K 5 pages Kiniksa Pharmaceuticals International, PLC 2018 Incentive Award Plan Performance Restricted Share Unit Grant Notice – Bla Filing Milestone

from 8-K 4 pages Kiniksa Pharmaceuticals International, PLC 2018 Incentive Award Plan Performance Cash Award Grant Notice – FDA Approval Milestone

from 8-K 4 pages Kiniksa Pharmaceuticals International, PLC 2018 Incentive Award Plan Performance Cash Award Grant Notice – Bla Filing Milestone

from 8-K 9 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10)(iv). Such Excluded Information Is Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. Kiniksa Pharmaceuticals International, PLC Kpl-387 Long-Term Incentive Plan (Vp+ Employees – Executive Officers) Effective Date: April 17, 2025

from 10-K 3 pages Kiniksa Pharmaceuticals International, PLC. Non-Employee Director Compensation Program

from 10-K 6 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(a)(6) Consulting Agreement

from 10-K 9 pages Employment Agreement

from 10-K 7 pages Change in Control Agreement

from 10-K 9 pages Employment Agreement